44 results
8-K
EX-10.1
ARAV
Aravive Inc
11 Apr 23
Aravive Appoints Carolina Petrini as Chief Commercial Officer
7:10am
for nor entitled to receive overtime compensation.
In addition, you will be eligible to be considered for a discretionary incentive and retention
8-K
EX-10.1
vz80xc o0k
5 Jul 22
Aravive Appoints Dr. Robert B. Geller as Chief Medical Officer
7:05am
8-K
EX-10.1
dltmv9v0l4u
3 Jun 22
Aravive Appoints Rudy Howard as Chief Financial Officer
4:06pm
8-K
EX-10.1
6e7rdg5dujrq9h e31
22 Mar 22
Aravive Appoints Scott Dove, Ph.D., as Chief Operating Officer
4:06pm
8-K
csz1sir
22 Mar 22
Aravive Appoints Scott Dove, Ph.D., as Chief Operating Officer
4:06pm
8-K
EX-99.2
8izexan6vv e1qu
23 Jul 20
Aravive Announces Successful Completion of Phase 1b Trial Evaluating AVB-500
7:05am
8-K
EX-99.2
z2s1jrn
27 Mar 20
AVB-500 Phase 1b dose escalation ongoing at 20 mg/kg dose in platinum resistant ovarian cancer with potential for topline data in summer 2020
8:05am